Umberto Basso
Istituto Oncologico Veneto(IT)Istituti di Ricovero e Cura a Carattere Scientifico(IT)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Prostate Cancer Treatment and Research, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma(2021)1,675 cited
- → Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations(2014)759 cited
- → Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial(2017)478 cited
- → Treatment of Estrogen Receptor-Positive Breast Cancer(2013)293 cited
- → Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 mg/kg Plus Ipilimumab 3 mg/kg Expansion Cohort Results(2019)242 cited
- → Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab